Paxor
Paxor Uses, Dosage, Side Effects, Food Interaction and all others data.
Paxor is a benzodiazepine which is a dimethyl carbamate ester of tamzepam, a metabolite of diazepam. Similarly to other drugs in its class, it has antxiolytic, anticonvulsant, hypnotic, and skeletal muscle relaxant properties. However, unlike other benzodiapeines camazepam is predominantly anxiolytic and is relatively weak as an anticonvulsant, hypnotic and skeletal muscle relaxant.
Paxor also has less side effects, such as impaired cognition and reaction times, compared to other benzodiazepines. However, impairment of cognition and disrupted sleep patterns will occur at doses higher than 40mg of carazepam. Paxor is also believed to increase attention, and is associated with skin disorders.
In the United States camazepam is regulated as a Schedule IV controlled substance.
Trade Name | Paxor |
Generic | Camazepam |
Camazepam Other Names | Camazepam |
Type | |
Formula | C19H18ClN3O3 |
Weight | Average: 371.818 Monoisotopic: 371.103669164 |
Groups | Experimental, Illicit |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Paxor has been used in placebo controlled studies for the treatment of patients suffering from anxiety and depression.
How Paxor works
Paxor has been shown to bind competitively to benzodiazepine receptors in the brain with a relatively low affinity in animal models. This binding of benzodiazepine receptors by camazepam and its active metabolites is responsible for its anticonvulsant effects. Notably, only three metabolites were shown to exert anticonvulsant activity, temazepam, oxazepam, and hydroxy camazepam.
The anxiolytic properties of camazepam are also attributed to their ability to bind benzodiazepine receptors, also known as GABA receptors. When benzodiazepines bind to GABA receptors they increase the efficiency with which the inhibitory neurotransmitter GABA binds.
Elimination Route
Almost completely absorbed into the bloodstream after oral administration. 90% bioavailability can be achieved in humans.
Elimination Route
Renally eliminated.
Innovators Monograph
You find simplified version here Paxor